Mechanism of retarded liver regeneration in plasminogen activator — Deficient mice: Impaired activation of hepatocyte growth factor after fas-mediated massive hepatic apoptosis

Hepatology

Volumn 33, Issue 3, 2001, Pages 569-576

  Shimizu, Masahito ^a,b   Hara, Akira ^a   Okuno, Masataka ^b   Matsuno, Hiroyuki ^c,d   Okada, Kiyotaka ^d   Ueshima, Shigeru ^d   Matsuo, Osamu ^d   Niwa, Masayuki ^c   Akita, Kuniharu ^b   Yamada, Yasuhiro ^a   Yoshimi, Naoki ^a   Uematsu, Toshihiko ^c   Kojima, Soichi ^e   Friedman, Scott L ^f   Moriwaki, Hisataka ^b   Mori, Hideki ^a  

^a Department of Pathology ^*  (Japan)

^b Health Sciences University of Hokkaido   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e RIKEN   (Japan)

^f MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PLASMINOGEN ACTIVATOR; SCATTER FACTOR;

ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; LIGAND BINDING; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 17744362678     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22650     Document Type: Article

References (45)

1. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration
2. Liver regeneration
3. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type 1 rumor necrosis factor receptor
4. Liver failure and defective hepatocyte regeneration in interleukin-6 - Deficient mice
5. HGF in liver regeneration and tumor promotion
6. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo
7. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism
8. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver
9. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat
10. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes
11. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats
12. Type I plasminogen activator inhibitor gene expression following partial hepatectomy
13. Plasminogen activator inhibitoris an immediate early response gene in regenerating rat liver
14. Biochemical and biological aspects of the plasminogen activation system
15. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA
16. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
17. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration
18. Release of transforming growth factor-beta I from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin
19. The transforming growth factor-beta family
20. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
21. The Fas death factor
22. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
23. Lethal effect of the anti-Fas antibody in mice
24. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis
25. Physiological consequences of loss of plasminogen activator gene function in mice
26. Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice
27. Evaluation of cationic liposome suitable for gene transfer into pregnant animals
28. Bovine urokinase-type plasminogen activator and its receptor: Cloning and induction by retinoic acid
29. Liver regeneration: Methods for monitoring and their applications
30. Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats
31. Concanavalin A-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice
32. Liver regeneration is transiently impaired in urokinase-deficient mice
33. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor
34. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor X11a and hepatocyte growth factor activator
35. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor, Structural similarity of the protease precursor to blood coagulation factor X1I
36. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator
37. Proteolytic activation of hepatocyte growth factor in response to tissue injury
38. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction
39. Regulation of PAl-1 gene expression
40. Multiple transforming growth factor-beta - Inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells
41. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells
42. Increased 9, 13-di-cis-retinoic acid in rat hepatic fibrosis: Implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo
43. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
44. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis
45. Essential roles of the Fas ligand in the development of hepatitis